Questions answered about COVID-19 vaccine booster shots Vaccine Image / Generic (Source: Hawaii News Now) By Christian Piekos | April 20, 2021 at 5:17 AM CDT - Updated April 20 at 6:55 AM
SHREVEPORT, La. (KSLA) - Over 50 percent of adults in the United States have now received at least one dose of the COVID-19 vaccine, according to the Centers for Disease Control and Prevention (CDC).
With all Americans 16 and up now eligible to access these shots, some are already looking towards the future â wondering if a booster dose will be necessary.
The CEO of pharmaceutical company Pfizer says itâs âlikely,â while the chief executive of Moderna announced plans to have a booster ready this fall.
Change of the seasons wreaks havoc on allergy sufferers ktbs.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ktbs.com Daily Mail and Mail on Sunday newspapers.
Willis-Knighton announces changes to visitor policy in labor & delivery area As of Tuesday, April 6, 2021, Willis-Knighton Labor & Delivery departments are allowing expectant mothers to have two visitors during delivery. (Source: Willis-Knighton Health System) By Rachael Thomas | April 6, 2021 at 12:10 PM CDT - Updated April 6 at 4:36 PM
SHREVEPORT, La. (KSLA) - Willis-Knighton Health System has announced changes to its visitor policy for labor and delivery patients.
Like many other healthcare facilities in the nation and the world, Willis-Knighton made changes to its visitation policies in 2020 at the start of the COVID-19 pandemic. Now, as of Tuesday, April 6, 2021, the health system is allowing labor and delivery patients to have two visitors.
Willis-Knighton seeking participants for COVID-19 treatment clinical trial Willis-Knighton Health System is searching for participants for a COVID-19 related clinical trial. The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19. Willis-Knighton is one of 120 sites nationwide and is the only site in the region selected for the Regeneron study. (Source: Pexels) By Alex Onken | April 5, 2021 at 12:04 PM CDT - Updated April 5 at 12:04 PM
SHREVEPORT, La. (KSLA) - Willis-Knighton Health System is searching for participants for a COVID-19 related clinical trial.
The hospital system is expanding its clinical trial for the Regeneron monoclonal antibodies for outpatient treatment of people infected with COVID-19.